Annual Drug Patent Expirations for SEGLENTIS
Seglentis is a drug marketed by Kowa Pharms and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.
This drug has ninety-one patent family members in thirty-five countries.
The generic ingredient in SEGLENTIS is celecoxib; tramadol hydrochloride. One supplier is listed for this compound. Additional details are available on the celecoxib; tramadol hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com